Clayton, Dubilier & Rice today announced an agreement under which CD&R-managed funds will acquire Cynosure, LLC, a leader in medical aesthetics systems and technologies, from Hologic, Inc. (NASDAQ:HOLX).
Cynosure develops, manufactures and markets medical aesthetic treatment systems for dermatologists, plastic surgeons, medical spas and other health care practitioners. The company’s broad portfolio of products spans several major categories, including skin revitalization, body contouring, hair removal and women's health. Cynosure sells its products through a combination of direct sales and distributors in more than 130 countries and supports its provider partners with a range of technical, clinical and support services.
Read more at Clayton, Dubilier & Rice >>